Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Reliant Technologies IPO Will Support 2008 Launch Of Skin Repair Laser

This article was originally published in The Gray Sheet

Executive Summary

Aesthetic laser manufacturer Reliant Technologies will launch its Fraxel Re:pair system for treatment of severe skin conditions in the first quarter of 2008, supported by the proceeds of a proposed initial public stock offering of up to $95 million

You may also be interested in...



Thermage Bolsters Aesthetic Skin Treatment Offerings Via Reliant Purchase

Aesthetic device maker Thermage will market its ThermaCool radiofrequency energy-based skin tightening treatment alongside Fraxel laser-based skin resurfacing systems made by Reliant Technologies after acquiring the firm for $95 million in a deal announced July 7

Thermage Bolsters Aesthetic Skin Treatment Offerings Via Reliant Purchase

Aesthetic device maker Thermage will market its ThermaCool radiofrequency energy-based skin tightening treatment alongside Fraxel laser-based skin resurfacing systems made by Reliant Technologies after acquiring the firm for $95 million in a deal announced July 7

Reliant Technologies

Mountain View, Calif., aesthetics device maker announces 510(k) clearance July 2 of its Fraxel re:pair laser with Fractional Deep Dermal Ablation for ablation, coagulation and skin resurfacing based on data from an ongoing, 200-patient, 10-site clinical trial. In the first phase of the trial, over 75% of patients treated with Fraxel re:pair showed improved appearance of rhytids, vascular dyschromia, pigmentation and skin laxity. Two later phases are evaluating the device for scar treatment. Reliant's other lasers on the market include Fraxel re:store for skin resurfacing and scar and wrinkle treatment, and Fraxel re:fine for gentle skin rejuvenation...

Latest Headlines
See All
UsernamePublicRestriction

Register

MT025187

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel